As of May 2024 Takeda Pharmaceutical has a market cap of $42.01 Billion. This makes Takeda Pharmaceutical the world's 473th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $42.01 B | -6.74% |
2023 | $45.05 B | -7.11% |
2022 | $48.50 B | 13.56% |
2021 | $42.71 B | -24.96% |
2020 | $56.92 B | -8.14% |
2019 | $61.96 B | 136.23% |
2018 | $26.23 B | -40.77% |
2017 | $44.29 B | 35.96% |
2016 | $32.57 B | -17.68% |
2015 | $39.57 B | 19.85% |
2014 | $33.02 B | -9.04% |
2013 | $36.30 B | 2.57% |
2012 | $35.39 B | 1.67% |
2011 | $34.81 B | -9.45% |
2010 | $38.44 B | 18.49% |
2009 | $32.44 B | -29.16% |
2008 | $45.79 B |
On May 15th, 2024 the market cap of Takeda Pharmaceutical was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $367.42 B | 774.45% | ๐บ๐ธ USA |
Novartis NVS | $210.61 B | 401.24% | ๐จ๐ญ Switzerland |
Pfizer PFE | $163.65 B | 289.49% | ๐บ๐ธ USA |
Amgen AMGN | $171.14 B | 307.31% | ๐บ๐ธ USA |
Sanofi SNY | $125.81 B | 199.42% | ๐ซ๐ท France |
Merck MRK | $335.28 B | 697.94% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $94.23 B | 124.27% | ๐ฌ๐ง UK |
Seagen
SGEN | $43.15 B | 2.70% | ๐บ๐ธ USA |
Dr. Reddy's RDY | $11.79 B | -71.92% | ๐ฎ๐ณ India |